Please confirm you are human
(Sign Up for free to never see this)
← Back to Search
High-performance Liquid Chromatography Of Iodo-doxorubicin And Fluorescent Metabolites In Plasma Samples.
K. Mross, U. Mayer, K. Hamm, D. Hossfeld
Published 1990 · Chemistry, Medicine
This paper references
10.1200/JCO.1988.6.3.517
Pharmacokinetics and metabolism of epidoxorubicin and doxorubicin in humans.
K. Mross (1988)
Pharmacokinetics of 4'-deoxy-4'-iodo-doxorubicin in plasma and tissues of tumor-bearing mice compared with doxorubicin.
F. Formelli (1987)
10.1016/0006-2952(86)90550-2
Reduction by the gut microflora of animals and man.
I. Rowland (1986)
In vitro studies on anthracycline haloderivatives.
T. Facchinetti (1986)
10.1016/0002-9343(87)90212-9
Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.
R. G. Schwartz (1987)
This paper is referenced by
Forensic and Clinical Applications of Solid Phase Extraction
Michael J. Telepchak (2004)
10.1007/BF00686150
Effects of verapamil on the pharmacokinetics and metabolism of epirubicin
K. Mross (2004)
10.1007/BF00280945
Pharmacokinetics and metabolism of iodo-doxorubicin and doxorubicin in humans
K. Mross (2004)
10.1007/978-1-59259-292-0_10
Selected Solid Phase Extraction Applications in Drug Analysis
Michael J. Telepchak (2004)
10.1007/978-1-59259-292-0
Forensic and Clinical Applications of Solid Phase Extraction
Mba Michael J. Telepchak BS (2004)
10.1016/0731-7085(91)80061-D
Analysis of iododoxorubicin and its major impurity.
A. Farina (1991)
10.1007/BF00684854
Tissue disposition and plasma concentrations of idarubicin after intravesical therapy in patients with bladder tumors
K. Mross (2004)
10.1038/bjc.1998.192
Phase II trial of dexverapamil and epirubicin in patients with non-responsive metastatic breast cancer.
M. Lehnert (1998)
10.1016/0277-5379(90)90276-Y
Toxicity, pharmacokinetics and metabolism of iododoxorubicin in cancer patients.
K. Mross (1990)
10.1007/3-7643-7407-1_2
DNA-intercalators — the anthracyclines
K. Mross (2006)